Clostridium difficile: Epidemiology, diagnostic and therapeutic possibilities - A systematic review

Techniques in Coloproctology

Volumn 18, Issue 3, 2014, Pages 223-232

  Kazanowski, M ^a   Smolarek, S ^a   Kinnarney, F ^b   Grzebieniak, Z ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b ST MICHAEL'S HOSPITAL   (Ireland)

Author keywords

Clostridium difficile; Fulminant colitis; Nosocomial infections; Pseudomembranous colitis

Indexed keywords

AMINOGLYCOSIDE; MACROLIDE; METRONIDAZOLE; SULFONAMIDE; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; APPENDICITIS; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE ASSOCIATED ENTERITIS; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; COST OF ILLNESS; DIVERTING LOOP ILEOSTOMY WITH COLONIC LAVAGE; ELDERLY CARE; ENTERITIS; ENZYME IMMUNOASSAY; FECAL TRANSPLANT; FULMINANT COLITIS; HUMAN; ILEOSTOMY; INFECTION RISK; INTESTINE PERFORATION; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; OPERATION DURATION; PRACTICE GUIDELINE; PSEUDOMEMBRANOUS COLITIS; REVIEW; SIGMOIDOSCOPY; SYSTEMATIC REVIEW; TOXIC MEGACOLON; TRANSPLANTATION;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS;

EID: 84898893827     PISSN: 11236337     EISSN: 1128045X     Source Type: Journal    
DOI: 10.1007/s10151-013-1081-0     Document Type: Review

References (43)

1. Hall C, O'Toole E (1935) Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child 49:390-402
2. Hambre M, Rake G, McKee M et al (1943) The toxicity of penicillin as prepared for clinical use. Am J Med Sci 206:642-652
3. Green RH (1974) The association of viral activation with penicillin toxicity in guinea pigs and hamsters. Yale J Biol Med 47:166-181
4. Cohen E, McNeill J, Wells F (1973) Clindamycin-associated colitis. J Am Med Ass 223:1379-1380
5. Tadesco J, Barton W, Alpers H (1974) Clindamycin-associated colitis: a prospective study. Ann Intern Med 81:429-433
6. Riegler M, Sedivy R, Pothoulakis C et al (1995) Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J Clin Invest 95:2004-2011
7. Brito A, Sullivan W, Ciesla P et al (2002) Clostridium difficile toxin A alters in vitro-adherent neutrophil morphology and function. J Infect Dis 185:1297-1306
8. Akerlund T, Svenungsson B, Lagergren A et al (2006) Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates. J Clin Microbiol 44:353-358
9. Pepin J, Valiquette L, Alary E et al (2004) Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171:466-472
10. Pepin J, Valiquette L, Cossette B (2005) Mortality attributable to nosocomial Clostridium difficile-associated disease during epidemic caused by a hypervirulent strain in Quebec. CMAJ 173:1037-1042
11. Hall J, Curns T, McDonald C, Parashar UD, Lopman BA (2012) The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis 55:216-223
12. Riggs M, Sethi K, Zabarsky F et al (2007) Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 45:992-998
13. Shim K, Johnson S, Samore H et al (1998) Primary symptomless colonization by Clostridium difficile and decreased risk of subsequent diarrhea. Lancet 351:663-666
14. Loo G, Bourgault M, Poirier L et al (2011) Host and pathogen factors for Clostridium difficile infection and colonization. N Eng J Med 365:1693-1703
15. McFarland V, Mulligan E, Kwok Y et al (1989) Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 26:204-210
16. Lawrence J (2007) Contemporary management of Clostridium difficile-associated disease. Gastroenterol Endosc News Speed 5:35-40
17. Adams D, Mercer W (2007) Fulminant Clostridium difficile colitis. Curr Opin Crit Care 13:450-455
18. Wanahita A, Goldsmith A, Marino J et al (2003) Clostridium difficile infection in patients with unexplained leukocytosis. Am J Med 115:543-546
19. Fekety R, McFarland V, Surawicz M et al (1997) Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 24:324-333
20. Dallal M, Harbrecht G, Bojoukas J et al (2001) Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 235:363-372
21. Lamontagne F, Labbé AC, Haeck O et al (2007) Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg 245:267-272
22. Vesoulis Z, Williams G, Matthews B (2000) Pseudomembranous enteritis after proctocolectomy: report of a case. Dis Colon Rectum 43:551-554
23. Brown A, Rajappannair L, Dalton B et al (2007) Acute appendicitis in the setting of Clostridium difficile colitis: case report and review of the literature. Clin Gastroenterol Hepatol 9:969-971
24. Turgeon K, Novicki J, Quick J et al (2003) Six rapid tests for direct detection of Clostridium difficile and its toxin in fecal samples compared with the fibroblast cytotoxicity assay. J Clin Microbiol 41:667-670
25. Kachrimanidou M, Malisiovas N (2011) Clostridium difficile infection: a comprehensive review. Crit Rev Microbiol 37:178-187
26. Hookman P, Barkin S (2009) Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol 15:1554-1580
27. Bartlett G (2002) Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 346:334-349
28. Hu Y, Katchar K, Kyne L et al (2009) Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Gastroenterology 136:1206-1214
29. Drekonja M, Butler M, MacDonald R et al (2011) Comparative effectiveness of Clostridium difficile treatments: a systematic review. Ann Intern Med 155:839-847
30. Zar A, Bakkanagari R, Moorthi M et al (2007) A comparison of vancomycin and metronidazole for treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 45:302-307
31. Fekety R, Silva J, Kauffman C et al (1989) Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Am J Med 86:15-19
32. Lowy I, Molrine DC, Leav BA et al (2010) Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 362:197-205
33. Cohen H, Gerding N, Johnson S et al (2012) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31:431-455
34. Apisarnthanarak A, Razavi B, Mundy M (2002) Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature. Clin Infect Dis 35:690-696
35. Sailhamer A, Carson K, Chang Y et al (2009) Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg 144:433-439
36. Butala P, Divino D (2010) Surgical aspects of fulminant Clostridium difficile colitis. Am J Surg 200:131-135
37. Al-Abed Y, Gray E, Rothnie N (2010) Outcomes of emergency colectomy for fulminant Clostridium difficile colitis. Surgeon 8:330-333
38. Perera A, Akbari R, Cowher M (2010) Colectomy for fulminant Clostridium difficile colitis: predictors of mortality. Am Surg 76:418-421
39. Neal D, Alverdy C, Hall E et al (2011) Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Ann Surg 254:423-427
40. Gustafsson A, Lund-Tonnesen S, Berstad A et al (1998) Faecal short-chain fatty acids in patients with antibiotic-associated diarrhea, before and after faecal enema treatment. Scand J Gastroenterol 33:721-727
41. Garey W, Ghantoji S, Shah N et al (2011) A randomized, doubled-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhea in patients with Clostridium difficile infection. J Antimicrob Chemother 66:2850-2855
42. Juand P, Skledar J, Zgheib K et al (2007) Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea. Am J Infect Control 35:131-137
43. McFarland V (2006) Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 101:812-822